Therapeutic strategy using novel RET/YES1 dual-target inhibitor in lung cancer.
Choi YJ, Choi M, Park J, Park M, Kim MJ, Lee JS, Oh SJ, Lee YJ, Shim WS, Kim JW, Kim MJ, Kim YC, Kang KW.
Choi YJ, et al. Among authors: choi m.
Biomed Pharmacother. 2024 Feb;171:116124. doi: 10.1016/j.biopha.2024.116124. Epub 2024 Jan 9.
Biomed Pharmacother. 2024.
PMID: 38198957
Free article.